Results

Looking for more? ProQuest® Dissertations & Theses has additional dissertations and theses.
1123 open access dissertations and theses found for:
if(SST4 Agonist SMI-26)  »   Refine Search
1.
Mitigation of Activated Microglia Associated Pathways by SST4 Agonist SMI-26
by House, Austin, M.S.  Southern Illinois University at Edwardsville. 2020: 93 pages; 27958029.
2.
Lead Optimization of Triazole-Based Somatostatin Subtype-4 Agonist for the Treatment of Alzheimer’S Disease
by Frare, Rafael F., M.S.  Southern Illinois University at Edwardsville. 2020: 107 pages; 27838098.
3.
Synthesis and Structure-Activity Studies of 3,4,5-Trisubstituted -1,2,4- Triazoles as Somatostatin Subtype -4-Agonists
by Srabony, Khush Nahar, M.S.  Southern Illinois University at Edwardsville. 2020: 114 pages; 28031272.
4.
Novel Somatostatin Receptor Subtype-4 Agonist Mitigates Microglia Inflammatory Activation
by Silwal, Ashok, M.S.  Southern Illinois University at Edwardsville. 2019: 133 pages; 22592201.
5.
Developing Potential Somatostatin Subtype-4 Receptor Agonists (3-Thio-1,2,4-triazoles)
by Schnietz, Melinda, M.S.  Southern Illinois University at Edwardsville. 2019: 53 pages; 22592420.
6.
Lead Optimization of Triazole-based Somatostatin Subtype-4 Agonists for the Treatment of Alzheimer's Disease
by Minaeian, Mahsa, M.S.  Southern Illinois University at Edwardsville. 2017: 142 pages; 10616070.
8.
Modulation of Microglial Cell Activity by Somatostatin Receptor Agonist NNC 26-9100
by Polina, Jahnavi, M.S.  Southern Illinois University at Edwardsville. 2019: 62 pages; 22614951.
9.
Increased Microglial Survival by NNC 26-9100: A Somatostatin Subtype-4 Selective Agonist
by Walters, Field Delaryn, Jr., M.S.  Southern Illinois University at Edwardsville. 2017: 107 pages; 10275906.
11.
Agonist-Dependent Desensitization of MC4R and its Potential Therapeutic Implications
by Molden, Brent Matthew, Ph.D.  University of Arkansas for Medical Sciences. 2014: 153 pages; 3633755.
12.
Improving Treatment Adherence to Opioid Agonist Therapy Utilizing Mobile Technology
by Beaveridge, Jennifer Sara, D.N.P.  Grand Canyon University. 2019: 151 pages; 13903188.
13.
Insulin Receptor Activation: Studies with Insulin and an Insulin Receptor Agonist Monoclonal Antibody
by Bedinger, Daniel Hart, Ph.D.  University of California, Davis. 2014: 107 pages; 3706555.
14.
Studies of expression, signaling, and trafficking of the beta2-adrenergic receptor in response to beta-agonist
by Koryakina, Yulia, Ph.D.  University of Arkansas for Medical Sciences. 2009: 183 pages; 3357547.
15.
Chronic effects of GnRH agonist Deslorelin on myocardial GnRH receptor protein and messenger RNA
by Chamberlain, Paige A., M.S.  University of Wyoming. 2012: 104 pages; 1519459.
16.
The Effects of Lipid Stress on the Melanocortin-4 Receptor
by Cooney, Kimberly Ann, Ph.D.  University of Arkansas for Medical Sciences. 2018: 159 pages; 10823867.
17.
Characterization of Novel Molecular Scaffolds for Cannabinoid Receptor Ligands: Implications for Drug Development
by Ford, Benjamin M., Ph.D.  University of Arkansas for Medical Sciences. 2017: 261 pages; 10619141.
18.
Hospital-Based Services for Opioid Use Disorder: A Study of Supply-Side Attributes
by Priest, Kelsey Caroline, Ph.D.  Portland State University. 2019: 397 pages; 13428228.
19.
Molecular and Pharmacological Analysis of the Chemokine Receptor CCR6
by Julian, Bina, Ph.D.  Sackler School of Graduate Biomedical Sciences (Tufts University). 2017: 175 pages; 10254519.
22.
Interaction of 3-Cholorophenyl Guanidine with Mouse Serotonin Type 3A Receptor
by Khatri, Shailesh N., Ph.D.  University of the Sciences in Philadelphia. 2017: 144 pages; 10692986.
23.
Lipid Stress and Melanocortin-4 Receptor
by McDaniel, Faith Kennedy, Ph.D.  University of Arkansas for Medical Sciences. 2013: 155 pages; 3610330.
24.
Effects of cannabinoid receptor interacting protein (CRIP1a) on cannabinoid (CB1) receptor function
by Smith, Tricia Hardt, Ph.D.  Virginia Commonwealth University. 2009: 161 pages; 3387455.
25.
The use of molecular imaging to evaluate the efficacy of treatments for metastatic breast cancer
by Szafran, April Adams, Ph.D.  The University of Alabama at Birmingham. 2008: 113 pages; 3356373.
26.
Cannabinoid Regulation of Serotonin 2A (5-HT2A) Receptor Signaling
by Franklin, Jade M., Ph.D.  University of Kansas. 2013: 257 pages; 3589526.
27.
Cannabinoid receptor inverse agonists as novel therapeutic agents
by Seely, Kathryn A., Ph.D.  University of Arkansas for Medical Sciences. 2009: 170 pages; 3357550.
28.
Mechanisms of modulation of nicotinic acetylcholine receptors
by Demmerly, Arianna L., Ph.D.  University of Alaska Fairbanks. 2016: 205 pages; 10244902.
29.
Characterization of allosteric modulators of CB2 receptors as novel therapeutics for inflammatory diseases
by Rajasekaran, Maheswari, Ph.D.  University of Arkansas for Medical Sciences. 2011: 195 pages; 3454568.
30.
Design and Synthesis of Functionalized Mn(III) Dipyrromethene Complexes as Peroxynitrite Decomposition Catalysts
by Msengi, Eliwaza Naomi Shadrack, M.S.  Southern Illinois University at Edwardsville. 2014: 131 pages; 1572743.
1 - 30 of 1123 displayed.
  1    2    3    4    5    6    7    8    9    10    11   Next >
Copyright © 2020 ProQuest LLC. All rights reserved. Terms and Conditions Privacy Policy Cookie Policy
ProQuest